Unforgiving Wall Street
Executive Summary
Investment community is having a hard time reconciling the lost value from the aborted Glaxo Wellcome-SmithKline Beecham merger, SB Chairman Leschly acknowledges. Noting that SB added $56 mil. per day "including Saturdays and Sundays" to its market cap during 1997 before merger talks, Leschly lamented to Wharton New Ventures meeting, "I am still being abused by the institutions"